Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The drop in annual HIV incidence was especially apparent among young gay and bisexual men and in the South.
With federal funds, Florida State University’s College of Nursing will lead the Adolescent Medicine Trials Network for HIV Interventions.
In 2022, reported use of any illicit drug within the past year remained at or significantly below pre-pandemic levels for all grades.
A new global alliance launches to end AIDS in children by 2030. Currently, only half of children with HIV are on lifesaving treatment.
The Food and Drug Administration recently extended the indication for Cabenuva to include adolescents ages 12 and up.
After a long wait, the FDA authorizes Pfizer and Moderna vaccines for children as young as 6 months old.
The long-acting regimen will enable some adolescents to take their HIV treatment just six times a year.
Noninvasive imaging may be the best way to screen for NAFLD in this population.
The American Academy of Pediatrics recommends HIV testing for youth ages 15 and older. Updated guidance now includes PrEP and PEP.
Disparities in who gets a PrEP prescription and who doesn’t show up even among those with access to care.
The federal HIV funding goes to 31 local housing programs and seven global data collection centers.
Little HIV prevention research has included pregnant women for fear of adverse birth outcomes.
Immigrants and girls had worse HIV outcomes in this study.
The small single-site study will need to be replicated in a larger group of adolescents.
Better integration and transition planning was associated with higher rates of viral suppression among youth with HIV.
Supporting universal access to care and quality-of-life check-ins may be associated with better quality of life for teens with HIV.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.